Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survival
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survival
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 10, Issue 2, Pages e004346
Publisher
BMJ
Online
2022-02-26
DOI
10.1136/jitc-2021-004346
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Host IL-11 signaling suppresses CD4+ T cell-mediated anti-tumor responses to colon cancer in mice
- (2021) Jennifer Huynh et al. Cancer Immunology Research
- T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A+CD141+ cDC1 and CD14+ antigen-presenting cell recruitment
- (2021) Bas D Koster et al. Journal for ImmunoTherapy of Cancer
- Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- (2020) Rita Cabrita et al. NATURE
- B cells and tertiary lymphoid structures promote immunotherapy response
- (2020) Beth A. Helmink et al. NATURE
- Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination
- (2020) Ziena Abdulrahman et al. Journal for ImmunoTherapy of Cancer
- A pre‐existing coordinated inflammatory microenvironment is associated with complete response of vulvar high‐grade squamous intraepithelial lesions to different forms of immunotherapy
- (2020) Ziena Abdulrahman et al. INTERNATIONAL JOURNAL OF CANCER
- Donor monocyte–derived macrophages promote human acute graft-versus-host disease
- (2020) Laura Jardine et al. JOURNAL OF CLINICAL INVESTIGATION
- CD39 identifies the CD4+ tumor-specific T cell population in human cancer
- (2020) Kim E Kortekaas et al. Cancer Immunology Research
- Solo: Doublet Identification in Single-Cell RNA-Seq via Semi-Supervised Deep Learning
- (2020) Nicholas J. Bernstein et al. Cell Systems
- The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
- (2020) Shogo Kumagai et al. NATURE IMMUNOLOGY
- Cytotoxic T Cells swarm by homotypic chemokine signalling
- (2020) Jorge Luis Galeano Niño et al. eLife
- Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy
- (2020) Elham Beyranvand Nejad et al. Journal for ImmunoTherapy of Cancer
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Asymmetric paralog evolution between the “cryptic” gene Bmp16 and its well-studied sister genes Bmp2 and Bmp4
- (2019) Nathalie Feiner et al. Scientific Reports
- Antitumor properties of triptolide: phenotype regulation of macrophage differentiation
- (2019) Han Li et al. CANCER BIOLOGY & THERAPY
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- (2019) Barbara Burtness et al. LANCET
- A 40-Marker Panel for High Dimensional Characterization of Cancer Immune Microenvironments by Imaging Mass Cytometry
- (2019) Marieke E. Ijsselsteijn et al. Frontiers in Immunology
- ImaCytE: Visual Exploration of Cellular Micro-Environments for Imaging Mass Cytometry Data
- (2019) Antonios Somarakis et al. IEEE TRANSACTIONS ON VISUALIZATION AND COMPUTER GRAPHICS
- TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
- (2018) Daniele V. F. Tauriello et al. NATURE
- Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
- (2018) David F. McDermott et al. NATURE MEDICINE
- Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
- (2018) Robert L. Ferris et al. ORAL ONCOLOGY
- Lamin A/C augments Th1 differentiation and response against vaccinia virus and Leishmania major
- (2018) Raquel Toribio-Fernández et al. Cell Death & Disease
- Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer
- (2018) Erminia Massarelli et al. JAMA Oncology
- Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
- (2018) Christopher S. Garris et al. IMMUNITY
- Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer
- (2018) Rita Das et al. MOLECULAR CARCINOGENESIS
- A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8+ T Cells
- (2018) Kazuhiko Matsuo et al. Frontiers in Immunology
- histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data
- (2017) Denis Schapiro et al. NATURE METHODS
- Visual analysis of mass cytometry data by hierarchical stochastic neighbour embedding reveals rare cell types
- (2017) Vincent van Unen et al. Nature Communications
- The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012
- (2016) Kevin D. Shield et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor
- (2016) A. Pasetto et al. Cancer Immunology Research
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Nuclear Envelope Lamin-A Couples Actin Dynamics with Immunological Synapse Architecture and T Cell Activation
- (2014) J. M. Gonzalez-Granado et al. Science Signaling
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma
- (2013) P.J. de Vos van Steenwijk et al. INTERNATIONAL JOURNAL OF CANCER
- Suppression of antigen-specific CD4+ T cell activation by SRA/CD204 through reducing the immunostimulatory capability of antigen-presenting cell
- (2011) Huanfa Yi et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
- (2010) K. Kian Ang et al. NEW ENGLAND JOURNAL OF MEDICINE
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
- (2009) Gabriela Bindea et al. BIOINFORMATICS
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression
- (2009) Chiara Gabellini et al. EUROPEAN JOURNAL OF CANCER
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
- (2009) Jean-Pierre Pignon et al. RADIOTHERAPY AND ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started